Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human Midkine Protein (Fc Tag) (AC1045)
Cat.#: ACPP-1045
Specifications
Despition Recombinant Human Midkine Protein (Fc Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence MDK (Val21-Asp143) + hFc (Glu99-Ala330) Molecular Weight 39.6 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1576 Human YWHAE Protein (AC1576) 5 µg inquiry ACPP-1385 Human TGFBI Protein (AC1385) 5 µg inquiry ACPP-1694 Mouse FGF 1 Protein, His (AC1694) 5 µg inquiry ACPP-1697 Mouse Midkine Protein (AC1697) 5 µg inquiry ACPP-1699 Human Human Prealbumin (Active) Protein (AC1699) 1 mg inquiry ACPP-1098 Synthetic Nanodisc Human CD133 Protein (AC1098) 10 µg inquiry ACPP-1459 Human Midkine Protein, His (AC1459) 5 µg inquiry ACPP-1021 Recombinant Human PGP9.5 Protein (Fc Tag) (AC1021) 50 µg inquiry ACPP-1228 Mouse IL 6 Protein (AC1228) 2 µg inquiry ACPP-1508 Human I TAC Protein (AC1508) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket